Mutant isocitrate dehydrogenase driven metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition
文献类型：期刊论文
| 作者 | Bi, Aiwei2; Xu, Jun2; Jin, Nan2; Lan, Xiaojing2 ; Tang, Shuai2; Shou, Matthew1; Liu, Jia2; Ding, Jian2; Geng, Meiyu2; Lin, Shuhai3
|
| 刊名 | CANCER RESEARCH
 |
| 出版日期 | 2020-08-01 |
| 卷号 | 80期号:16页码:2 |
| ISSN号 | 0008-5472 |
| DOI | 10.1158/1538-7445.AM2020-3737 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| WOS记录号 | WOS:000590059305309 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/295709]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA 2.Shanghai Inst Mat Med, Shanghai, Peoples R China 3.Xiamen Univ, Xiamen, Peoples R China |
| 推荐引用方式 GB/T 7714 | Bi, Aiwei,Xu, Jun,Jin, Nan,et al. Mutant isocitrate dehydrogenase driven metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition[J]. CANCER RESEARCH,2020,80(16):2. |
| APA | Bi, Aiwei.,Xu, Jun.,Jin, Nan.,Lan, Xiaojing.,Tang, Shuai.,...&Huang, Min.(2020).Mutant isocitrate dehydrogenase driven metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition.CANCER RESEARCH,80(16),2. |
| MLA | Bi, Aiwei,et al."Mutant isocitrate dehydrogenase driven metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition".CANCER RESEARCH 80.16(2020):2. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。